Trump's offshore tax plan would benefit Apple, Pfizer
Previous accounting manoeuvres mean that Apple and Pfizer could enjoy even bigger benefits than other US corporates from President Donald Trump's proposed tax cut on US companies' stockpiled overseas earnings.
Exclusive subscriber content…
If you are a
TXF subscriber, please login to continue reading
Login
Not yet a subscriber? Join us today to continue accessing content without any restrictions
View our subscription options
Or to request access to TXF Intelligence contact us
Request Access